GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma

$82,478
Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Functional and Therapeutic Significance of PLK4 in Melanoma

$82,457
Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2025 · CA

Functional and Therapeutic Significance of PLK4 in Melanoma

$82,457
Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2024 · CA

A physical sciences approach to investigate the role of exosomes in metastatic progression

$82,448
Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2022 · CA

Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD

$82,361
Richard M Longnecker · Northwestern University At Chicago · R01 · FY2010 · CA

Spatial and mechanistic assessment of the role of stromal fibroblasts in driving emergence of aggressive prostate and bladder cancer

$82,234
Angelo Michael De Marzo · Johns Hopkins University · U54 · FY2023 · CA

Analysis of Type 1 Diabetes Polygenic Scores in Atypical Forms of Diabetes

$82,179
Aaron Jonathan Deutsch · Massachusetts General Hospital · F32 · FY2023 · DK

Cyclin-Dependent Kinase Inhibition During S Phase

$82,084
Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2014 · CA

Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface

$81,978
Melody A Swartz · University Of Chicago · R01 · FY2022 · CA

Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface

$81,975
Melody A Swartz · University Of Chicago · R01 · FY2023 · CA

Evaluating the relationship between immune checkpoint inhibitors and osteoarthritis

$81,875
Laura Christine Cappelli · Johns Hopkins University · R03 · FY2024 · AR

Evaluating the relationship between immune checkpoint inhibitors and osteoarthritis

$81,875
Laura Christine Cappelli · Johns Hopkins University · R03 · FY2023 · AR

(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors

$81,816
Kevan C Herold · Yale University · R01 · FY2019 · CA

Diversity Supplement - Targeting Wnt signaling in therapy-resistant ovarian cancer

$81,678
Benjamin G Bitler · University Of Colorado Denver · R37 · FY2023 · CA

Enhancing the Immune System by Targeting the RAS Signaling Pathway in Cancer: Immunotherapeutic Potential of a Novel RAS Inhibitor for lung cancer treatment.

$81,635
Gary A Piazza · University Of South Alabama · R01 · FY2019 · CA

Uncovering actionable signaling pathways required for solid tumor brain metastasis

$81,525
Jacob Peter Hoj · Duke University · K00 · FY2020 · CA

Cancer Immunology Research Program

$81,519
Marcus W Bosenberg · Yale University · P30 · FY2024 · CA

Radiobiology and Imaging Program

$81,482
Theresa M Busch · University Of Pennsylvania · P30 · FY2025 · CA

Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer

$81,338
Christopher J. Halbrook · University Of California-Irvine · R00 · FY2022 · CA

The frequency and function of Type 3 Innate Lymphoid Cells regulates the melanoma tumor microenvironment

$81,040
Margaret O'Connor · Duke University · F32 · FY2025 · CA

Visualizing B Cell Infiltration and Aggregation Within the Tumor Microenvironment

$81,040
Gabrielle Nicole Rowe · Johns Hopkins University · F32 · FY2025 · CA

Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis

$81,000
Dimitrios P Kontoyiannis · University Of Tx Md Anderson Can Ctr · R03 · FY2022 · AI

Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis

$81,000
Dimitrios P Kontoyiannis · University Of Tx Md Anderson Can Ctr · R03 · FY2023 · AI

Regulation of cyclosome/APC in the human cell cycle

$81,000
Technion-Israel Institute Of Technology · R01 · FY2005 · GM

Regulation of cyclosome/APC in the human cell cycle

$81,000
Technion-Israel Institute Of Technology · R01 · FY2004 · GM